MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma
- 6 March 2014
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 123 (10) , 1499-1511
Abstract
Key Points: Aberrantly diminished expression of miR-150 allows advanced CTCL to invade multiple organs with upregulation of CCR6. MiR-150 inhibits IL-22-CCL20-CCR6 autocrine signaling in advanced CTCL.Keywords
This publication has 43 references indexed in Scilit:
- MicroRNA expression in Sézary syndrome: identification, function, and diagnostic potentialBlood, 2010
- Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodelingJournal of Clinical Investigation, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis PathogenesisJournal of Investigative Dermatology, 2009
- MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypesBlood, 2009
- Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphomaLeukemia, 2008
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- Synergistic action of the microRNA‐17 polycistron and Myc in aggressive cancer developmentCancer Science, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- Prediction of Mammalian MicroRNA TargetsCell, 2003